New Obesity Drug in Trials

The new drug takes the old methods used to make other weight reduction pills and refines them considerably, to become the first therapy that is to inhibit the synaptic activity of several hormones, including noradrenaline, dopamine and serotonine. When tested on Alzheimer patients, for potent... [ read more >> ]